DelMar Pharmaceuticals Presents Poster at AACR’s Ovarian Cancer Special Conference on the Mechanistic Rationale for VAL-083 Overcoming Treatment Resistance in Ovarian Cancer Oct 3, 2017 Life Science
RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Oct 3, 2017 Life Science
RedHill Biopharma Accelerates RHB-104 Phase III Study in Crohn’s Disease with Top-Line Results Expected Mid-2018 Oct 2, 2017 Life Science
Southern Silver Closes Final Tranche of Financing Vancouver, British Columbia Oct 2, 2017 Life Science
Preferred Dental Technologies Inc. (“Company”) (CSE: PDT): Preferred Dental Implant Corp. announces EAS product now ready for sale, additional R&D initiatives nearing completion Oct 2, 2017 Life Science
Search Closes $150,000 of the Secured Convertible Debenture and Announces Board Changes Oct 2, 2017 Life Science
